Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone dose comparison for prevention of postoperative remifentanil-associated hyperalgesia after hysterectomy
IRCT20180723040570N5Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone in postoperative pain and opioid-induced hyperalgesia (OIH) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Visual Analog Scale, Ramsay score and 1 more. Started Jul 2020; status: completed.
02
Drugs
naloxone
03
Conditions
postoperative painopioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on IRCT20180723040570N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180723040570N5.